Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non Operating Investment Income: 2022-2024

Historic Non Operating Investment Income for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$68,000.

  • Orchestra BioMed Holdings' Non Operating Investment Income fell 76.03% to $29,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183,000, marking a year-over-year increase of 24.07%. This contributed to the annual value of -$68,000 for FY2024, which is 277.78% down from last year.
  • Orchestra BioMed Holdings' Non Operating Investment Income amounted to -$68,000 in FY2024, which was down 277.78% from -$18,000 recorded in FY2023.
  • Over the past 5 years, Orchestra BioMed Holdings' Non Operating Investment Income peaked at $1.0 million during FY2022, and registered a low of -$68,000 during FY2024.
  • Over the past 3 years, Orchestra BioMed Holdings' median Non Operating Investment Income value was -$18,000 (recorded in 2023), while the average stood at $315,000.
  • Data for Orchestra BioMed Holdings' Non Operating Investment Income shows a maximum YoY tumbled of 277.78% (in 2024) over the last 5 years.
  • Orchestra BioMed Holdings' Non Operating Investment Income (Yearly) stood at $1.0 million in 2022, then slumped by 101.75% to -$18,000 in 2023, then crashed by 277.78% to -$68,000 in 2024.